SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-114862
Filing Date
2023-11-07
Accepted
2023-11-06 18:16:05
Documents
13
Period of Report
2023-11-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330019d1_8k.htm   iXBRL 8-K 24805
2 EXHIBIT 23.1 tm2330019d1_ex23-1.htm EX-23.1 2978
  Complete submission text file 0001104659-23-114862.txt   199613

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20231106.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20231106_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20231106_pre.xml EX-101.PRE 22369
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2330019d1_8k_htm.xml XML 3173
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36081 | Film No.: 231381064
SIC: 2834 Pharmaceutical Preparations